Hickman, Alison B.
Lannes, Laurie
Furman, Christopher M.
Hong, Christina
Franklin, Lidiya
Ghirlando, Rodolfo
Ghosh, Arpita
Luo, Wentian
Konstantinidou, Parthena
Lorenzi, HernĂ¡n A. https://orcid.org/0000-0003-0910-7894
Grove, Anne https://orcid.org/0000-0002-4390-0354
Haase, Astrid D. https://orcid.org/0000-0003-1120-9013
Wilson, Matthew H. https://orcid.org/0000-0002-3776-8350
Dyda, Fred https://orcid.org/0000-0003-1689-9041
Funding for this research was provided by:
Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health (R01 DK093660, R01 EB033676, P30 DK114809)
National Science Foundation (MCB-2153410)
Article History
Received: 20 June 2024
Accepted: 27 December 2024
First Online: 7 January 2025
Competing interests
: This work was partially funded by a Collaborative Research and Development Agreement DK22-1043 between the NIDDK and SalioGen Therapeutics. M.H.W. previously served on the scientific advisory board of SalioGen. A.B.H., C.M.F., and F.D. have submitted a patent application (No. 63/632,275) that covers modifications to the <i>piggyBat</i> transposon system that increase its activity. The remaining authors declare no competing interests.